Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Elucidating the role of ketone bodies in hepatic PUFA homeostasis and MASLD-MASH progression

Award Number: F31DK146624
ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 06/01/2026
PERIOD OF PERFORMANCE END DATE: 05/31/2028

Group Awards By:

View Award Description

Elucidating the role of ketone bodies in hepatic PUFA homeostasis and MASLD-MASH progression - PROJECT SUMMARY/ABSTRACT This project is fueled by candidate’s ambitions to build an independent academic research program at the intersection of biochemistry, physiology, and analytical chemistry, that explores intermediary lipid metabolism and shifts in subcellular lipid pools, to understand the molecular origins of metabolic diseases. This training project focuses on metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis (MASH) which are the leading cause of liver disease in Western countries. Due to complex systemic and liver- autonomous factors influencing MASLD-MASH development and progression, treatment options are scarce, triggering an urgent need to better understand the molecular origins to develop new drug targets. The primary objective of this project is to investigate the role of ketone body-sourced polyunsaturated fatty acids (PUFAs) in the development of MASLD-MASH, implicating ketogenesis as a potential therapeutic target. This project will test the central hypothesis that ketogenesis-derived carbon sources malonyl-CoA to hepatic PUFA elongation, via acetoacetyl-CoA synthetase (AACS), which protects against MASLD-MASH by suppressing absolute rates of hepatic de novo lipogenesis. In Aim 1, a convergence of subcellular fractionation and mass spectrometry (MS)-driven proteomics and stable isotope tracing will be leveraged to study the co-localization of AACS and PUFA elongation enzymes within peri-lipid droplet mitochondria-associated membranes. In Aim 2, the hypothesis that ketone-sourced PUFAs protect against liver injury and inflammation will be tested using three loss-of-function mouse models, that strategically lack key ketone body metabolic enzymes, and a suite of physiological and analytical methodologies to quantify indices of liver metabolism and injury. These findings will deepen our understanding of the link between ketogenesis, PUFAs, and liver injury, and in so doing, implicate interventions such as intermittent fasting or low-carbohydrate diets that provoke ketosis as therapeutic options during MASLD-MASH. This project will take place in the Division of Molecular Medicine at the University of Minnesota Medical School. Molecular Medicine houses multiple labs focused on leveraging cutting-edge analytical tools to acquire high resolution molecular and phenotypical profiles, to better understand the metabolic underpinnings of human diseases. In this environment, and in conjunction with my co-sponsors, collaborators, and consultants, the outlined training plan will (1) provide proficiencies in subcellular fractionation, proteomics, and specialized training in shotgun lipidomics, and (2) provide experiences leveraging these tools to study in vivo diseases using dietary and genetic mouse models. Collectively, this will generate a unique and highly personalized training experience to prepare for a career focused on studying the molecular origins of metabolic diseases.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $35,783 )
2026	2026	REGENTS OF THE UNIVERSITY OF MINNESOTA	2221 UNIVERSITY AVE SE STE 100	MINNEAPOLIS	MN	55414	HENNEPIN	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	001	1	3/19/2026	NEW	$0
2026	2026	REGENTS OF THE UNIVERSITY OF MINNESOTA	2221 UNIVERSITY AVE SE STE 100	MINNEAPOLIS	MN	55414	HENNEPIN	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	1	3/19/2026	NEW	$35,783
														Subtotal = $35,783

Grand Total All Awards = $35,783

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Elucidating the role of ketone bodies in hepatic PUFA homeostasis and MASLD-MASH progression

Award Number: F31DK146624

ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 06/01/2026

PERIOD OF PERFORMANCE END DATE: 05/31/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer